Congress Park Capital’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,500
Closed -$208K 143
2022
Q3
$208K Sell
2,500
-150
-6% -$12.9K 0.12% 118
2022
Q2
$211K Sell
2,650
-3,818
-59% -$371K 0.13% 121
2022
Q1
$673K Buy
6,468
+3,300
+104% +$273K 0.34% 69
2021
Q4
$238K Hold
3,168
0.12% 123
2021
Q3
$205K Buy
+3,168
New +$194K 0.1% 123
2020
Q1
Sell
-6,456
Closed -$309K 100
2019
Q4
$309K Hold
6,456
0.23% 78
2019
Q3
$322K Hold
6,456
0.27% 68
2019
Q2
$328K Hold
6,456
0.26% 73
2019
Q1
$341K Hold
6,456
0.29% 69
2018
Q4
$303K Hold
6,456
0.33% 65
2018
Q3
$373K Sell
6,456
-100
-2% -$5.54K 0.33% 70
2018
Q2
$357K Hold
6,556
0.34% 68
2018
Q1
$310K Buy
+6,556
New +$328K 0.32% 73

Other funds holding NTR

Congress Park Capital's NTR Position: Q4 2022 in Review

Congress Park Capital sold out of Nutrien (NTR) in Q4 2022, closing a stake of 2,500 shares — an estimated $208K sold.

Congress Park Capital first reported a position in NTR in Q1 2018 and held it in 13 quarters. The position peaked at $673K in Q1 2022. 695 funds tracked by Wall St. Rank hold NTR as of Q4 2022.

  • Congress Park Capital reported no remaining Nutrien position as of Q4 2022 after selling out during the quarter.
  • Congress Park Capital sold 2,500 Nutrien shares in Q4 2022, an estimated $208K.
  • Congress Park Capital first reported a position in Nutrien in Q1 2018 and held it in 13 quarters.
  • Congress Park Capital's Nutrien position peaked at $673K in Q1 2022.
  • 695 funds tracked by Wall St. Rank held Nutrien as of Q4 2022.

Based on Congress Park Capital's 13F filing for Q4 2022, filed 30 Jan 2023.